FDA Expert Foresees Long-Term Planning Damage Due To Shutdown

January 02, 2019
Nearly two weeks into a government shutdown that has left 41 percent of FDA employees furloughed, an agency expert says the shutdown will disrupt FDA’s long-term planning because it will put off settling the question of how much funding the agency will receive from Congress in 2019. The shutdown will also slow down the process for some user fee-funded activities, he said. Steven Grossman, deputy executive director of the Alliance for a Stronger FDA, said his group is talking with...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.